Chemokine Receptor Type 4 Interaction [EPC]

1361 reported adverse events

Drugs of this class: MOGAMULIZUMAB-KPKC

These side effects are most commonly reported by patients taking drugs of the Chemokine Receptor Type 4 Interaction [EPC] class:

# Side effect Count
0 RASH 193
1 DISEASE PROGRESSION 123
2 DRUG ERUPTION 81
3 PRURITUS 68
4 INFUSION RELATED REACTION 59
5 DEATH 55
6 PYREXIA 52
7 FATIGUE 49
8 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 42
9 CHILLS 41
See all common reactions for Chemokine Receptor Type 4 Interaction [EPC]

Drugs of the Chemokine Receptor Type 4 Interaction [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CUTANEOUS T-CELL LYMPHOMA RECURRENT 5 0.0794
1 THERAPY NAIVE 4 0.0323
2 CYTOMEGALOVIRUS ENTERITIS 7 0.0197
3 ERYTHEMA ANNULARE 4 0.0138
4 BULBAR PALSY 3 0.0108
5 TUMOUR FLARE 7 0.0102
6 CYTOMEGALOVIRUS ENTEROCOLITIS 7 0.0091
7 PNEUMOCOCCAL INFECTION 5 0.0084
8 LYMPHOMA TRANSFORMATION 3 0.0083
9 CUTANEOUS T-CELL LYMPHOMA 9 0.0071
See all enriched reactions for Chemokine Receptor Type 4 Interaction [EPC]